Skip to content
Neuromyelitis News logo
  • About NMOSD
    What is NMOSD?
    Causes
    Symptoms
    Diagnosis
  • Treatments
    Approved treatments
  • News
  • Columns
    The Beginner’s Guide to Walking — Jennifer V.
    Archived Columns
    • Courage to Care — Candice Galvan
    • Strength of the Soul — Mileidys Almaguer Iniguez
    • The View From Here — Lelainia Lloyd
  • NMO spotlight
  • What can we help you find today?

August 24, 2023 News by Margarida Maia, PhD

Prednisolone may help slow the loss of brain white matter in NMOSD

Neuromyelitis optica spectrum disorder (NMOSD) is associated with a faster loss of white matter volume in the brain, but taking the corticosteroid prednisolone may help counter this effect, according to a small study in Japan. The brain’s white matter contains the long, wire-like projections, or fibers, that nerves use…

August 16, 2022 News by Margarida Maia, PhD

Aseptic Meningitis, Epstein-Barr Implicated in Rare Case of NMOSD

A man’s first manifestation of neuromyelitis optica spectrum disorder (NMOSD) was aseptic meningitis, an inflammation of the meninges (the membranes that enclose the brain and spinal cord) without evidence of a bacterial infection, which is unusual and made a quick diagnosis difficult, says a report from Japan. The man…

June 9, 2022 News by Patricia Inacio, PhD

Report: Immunomodulatory Type 1 Interferons May Spark NMOSD

The use of immunomodulatory therapy based on type 1 interferons (IFNs) may trigger neuromyelitis optica spectrum disorder (NMOSD), according to a new case report. Researchers in China described the case of a 24-year-old man diagnosed with the autoimmune disease after receiving treatment with IFN-alpha, a…

Recent Posts

  • Enspryng helps patients remain relapse-free after 6 months: Study
  • For me, preventing relapses involves harsh medication side effects
  • Smoking tied to disability risk in AQP4-NMOSD patients: Study
  • I have NMOSD, and I want to climb a volcano
  • Blood cell ratio may be biomarker of NMOSD disability: Study
  • Off-label tocilizumab works better when taken after 1st attack: Study
  • What’s the difference between generic and brand-name drugs?
  • Switching doctors with NMOSD: When and how to do it
  • Regular rituximab treatment lessens NMOSD relapses: Real-world data
  • After a difficult year due to NMOSD, it’s time to address my mental health


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.